معرفی
Christine Rollier is a Professor of Vaccinology at the University of Surrey, affiliated with the Section of Immunology in the School of Biosciences. She holds the title of Chevalier dans l'Ordre des Palmes Académiques. Her career includes roles at the University of Lyon, INSERM, and the Biomedical Primate Research Center in the Netherlands, before joining the University of Surrey and becoming a visiting scientist at the Oxford Vaccine Group (since 2021). Her research focuses on vaccine development across preclinical to clinical stages, with expertise in viral-vector vaccines, antimicrobial resistance, and vulnerable populations.
Education: PhD in Biochemistry (2000, University of Lyon), specializing in DNA immunization against Hepatitis B. She has pioneered work on Hepatitis C vaccines and contributed to the Oxford/AstraZeneca COVID-19 vaccine. Her research emphasizes OneHealth approaches and global health equity.
Research highlights include early-stage trials of MenB vaccines and genetic vaccines targeting bacterial infections. She advocates for Franco-British research collaborations and emphasizes work-life balance, currently working part-time to sustain creativity.
Scientific contributions include over 60 publications, with recent work on adenoviral vectored vaccines, antimicrobial resistance strategies, and immune response mechanisms in aging populations. Her awards include the Chevalier honor, recognizing her contributions to science and education.
Grants and partnerships focus on translational vaccinology, with collaborations across Europe and the UK. She leads initiatives to bridge academic research with clinical applications, particularly in low-resource settings.